Fibroids and IVF planning: which features may change the decision

A fibroid on an ultrasound report does not automatically mean it should be removed before IVF. Its location, relationship to the uterine cavity, symptoms and the wider fertility situation matter. “A fibroid of this size” is not enough to establish the benefit of surgery: two fibroids with the same diameter can present different clinical questions.

Look beyond the measurement

Fibroids are non-cancerous growths in or around the womb. Ultrasound helps describe their number, size and location. Before fertility treatment, a particularly relevant question is whether a fibroid changes the shape of the uterine cavity. If the report does not address that, ask for the anatomy to be clarified rather than arranging another procedure yourself.

Keep the complete report and available images. Include the date, earlier investigations and any operations on the uterus. If a numbered classification is used, request a plain-language explanation of where the fibroid is and which question that raises for the proposed treatment.

Different reasons for considering surgery

ASRM allows consideration of removing cavity-distorting fibroids to improve pregnancy rates. For asymptomatic fibroids that do not distort the cavity, surgery solely to improve reproductive outcomes is generally not advised, although individual exceptions exist. The evidence does not support a universal decision based on size alone.

It is therefore useful to separate two assessments: does the finding affect the IVF plan, and is it causing symptoms that need treatment in their own right? Heavy bleeding, pain or other concerns should not disappear from the discussion because pregnancy is the main goal. At the same time, symptoms do not automatically determine which intervention is most appropriate.

Compare surgery with a defined observation plan

The assessment should explain why a particular approach is proposed and when it would be reconsidered. If observation is advised, establish what will be monitored and which change would alter the decision. If surgery is offered, its scope needs to follow the identified problem, with risks and subsequent recovery explained.

Clarify the expected benefit: reducing bleeding, addressing cavity distortion or solving another problem. “Improving IVF chances” without the underlying reason is too vague for informed consent. Neither surgery nor choosing against it can guarantee a live birth.

Your intention to have children should be clear before a fibroid treatment is selected. Not every uterine treatment is equally suitable when pregnancy is intended. A procedure being described as less invasive does not demonstrate an advantage for a future pregnancy; the gynaecologist and fertility specialist should address that question together.

Set dates after the clinical decision

If an operation is recommended, identify who performs the review and what will establish readiness for the next fertility stage. Separate plans for egg collection, possible embryo storage and transfer if they are already under discussion. Do not derive your personal waiting time from a promotional description or another patient’s discharge letter.

Before travelling to Turkey, a concise question can guide the assessment: “My report describes this fibroid; does its relationship to the cavity need clarification, and does it change the proposed IVF plan?” Attach the records and explain whether you have symptoms. This helps obtain a relevant answer rather than another general offer of fibroid treatment.

If two specialists differ, the guide to comparing medical proposals can help record the reason for each approach. A second opinion is useful when it explains the difference, rather than simply making a more confident promise.

Sources

Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.